by draivika_incrowd | Aug 18, 2022
Judges commend InCrowd global instant market insights offering for life science as “a very elegant solution to the problem of getting quick insights from health care providers” WATERTOWN MA August 17, 2022—InCrowd, the pioneer of real-time, automated insights for...
by draivika_incrowd | Dec 1, 2021
However, doctors show less agreement on impact on outcomes, with 53% saying apps provide better health outcomes, 47% that apps are highly effective in managing T2D WATERTOWN, MA, December 1, 2021—As the...
by draivika_incrowd | Nov 3, 2021
Only 5% are concerned about potential risks of severe conditions such as myocarditis and/or pericarditis; 30% say their practices are performing extra outreach to families of color with eligible patient WATERTOWN, MA, November 3, 2021—New...
by draivika_incrowd | Oct 29, 2021
42% expect clinical trials will reconvene as soon as more data are released WATERTOWN, MA October 29, 2021—Despite the FDA’s recent hold on select chimeric antigen receptor (CAR) T-cell clinical trials for cancer treatments using allogeneic...
by draivika_incrowd | Oct 14, 2021
As key FDA committee meets this week, 86% of doctors agree on Pfizer-BioNTech COVID-19 booster shot importance for key groups, but estimate 18% of wishful patients will be ineligible WATERTOWN, MA October 14, 2021—As...